Menu
Slide background
Slide background
Slide background
Slide background

A number of medical societies and expert groups have issued guidelines on hereditary cancer testing. Myriad has formed its assessment criteria based on the following medical society guidelines. A healthcare provider may use assessment criteria based on medical society guidelines and his/her own professional judgment, these may differ from Myriad's assessment guidelines.

Start Now
E-Learning

A practical and educational approach to making Hereditary Cancer Risk Assessment work in your practice.

Learn More
Hereditary
Cancer Quiz

An online Hereditary Cancer Quiz that can help you identify appropriate patients for hereditary cancer testing before your patient's scheduled appointment.

Watch Videos Now
Patient
Education Videos

Tools to help appropriate patients understand hereditary cancer testing and answer common questions.

Learn More
Financial Assistance

At Myriad, we believe that testing should be available to all eligible patients; therefore we strive to make sure there is a financial option for all.

Myriad Products
Left Navigation Arrow Right Navigation Arrow

BRACAnalysis, COLARIS, COLARIS AP, MELARIS, Myriad myPath, myPlan, myRisk, TheraGuide, PREZEON, PANEXIA, and Prolaris are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions